Common Terminology Criteria for Adverse Events v3.0 (CTCAE)
By Cancer Program. 2003
951 citations recorded by the source corpus.
Subfields: Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/09fc29078cbb0982d64336bfbaeda88ed3202d68
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Statistics and Probability
- Allison O'Hair
- Dimitris J. Bertsimas
- John Silberholz
- Stephen Relyea
- Velibor V. Misic
- Jack Dunn
- Nathan Kallus
- Melvyn Sim
Citations in the corpus
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells (2018, neutral): “In the Common Terminology Criteria for Adverse Events version 3 (CTCAE v3 [10]), which was in effect when many of these studies began, CRS onset was de fi ned as within 24 hours of initiation of therapy, which is atypical for CRS associated with CAR T cells as well as other immune effector cell…”
- An Analytics Approach to Designing Combination Chemotherapy Regimens for Cancer (2016, methodology): “…spaced values (cid:52)(cid:54) 1 (cid:48) 5 − 4 (cid:52)v/ 3 All models were built and evaluated with the statistical language R version 3.0.1 (R Development Core Team 2011) using packages glmnet (Friedman et al. 2010a), randomForest (Liaw and Wiener 2002), and e1071 (Meyer et al. 2012).”